| 1 |
Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods [J]. International Journal of Cancer, 2019, 144(8): 1941-1953.
|
| 2 |
Yang Y, Han Z, Li X, et al. Epidemiology and risk factors of colorectal cancer in China [J]. Chinese Journal of Cancer Research, 2020, 32(6):729-741.
|
| 3 |
Zhu J, Tan Z, Hollis-Hansen K, et al. Epidemiological trends in colorectal cancer in china: an ecological study [J]. Dig Dis, 2017, 62(1):235-243.
|
| 4 |
Bo X, Dan H, Hu Y, et al. Prevalence of Metabolic Syndrome and Its influencing Factors Among the Chinese Adults: the China Health and Nutrition Survey in 2009 [J]. Preventive Medicine, 2013, 57(6):867-871.
|
| 5 |
Ma A, Fang K, Dong J, et al. Prevalence and Related Factors of Metabolic Syndrome in Beijing, China (Year 2017) [J]. Obesity Facts, 2020, 13(6):1-10.
|
| 6 |
Trabulo D. Metabolic syndrome and colorectal neoplasms: An ominous association [J]. World Journal of Gastroenterology, 2015, 21(17): 5320-5327.
|
| 7 |
Kim J, Park EY, Park E, et al. Metabolic Syndrome and Colorectal Cancer Risk: Results of Propensity Score-Based Analyses in a Community-Based Cohort Study [J]. International Journal of Environmental Research and Public Health, 2020, 17: 8687.
|
| 8 |
McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome [J]. Clinics in Dermatology, 2018, 36(1):14-20.
|
| 9 |
Chen DZ, Ji FY, Xu QM, et al. Interaction of smoking and metabolic syndrome in increasing the recurrence risk of colorectal cancer in a Chinese male cohort: a retrospective study [J]. Scientific Reports, 2018, 8(1):972.
|
| 10 |
Battelli MG, Bortolotti M, Polito L, et al. Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase [J]. Redox Biology, 2019, 21: 101070.
|
| 11 |
Jin CY, Ho LD, Han KD, et al. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer [J]. European Journal of Epidemiology, 2018, 33:1077-1085.
|
| 12 |
Peng F, Hu D, Lin X, et al. Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study [J]. International Journal of Cancer, 2016, 139(12):2705-2713.
|
| 13 |
Sipos Ferenc, Székely Hajnal, Dániel Kis Imre, et al. Relation of the IGF/IGF1R system to autophagy in colitis and colorectal cancer [J]. World Journal of Gastroenterology, 2017, 23(46): 8109-8119.
|
| 14 |
廉颖, 王林平, 梁婧, 等. 基于病例对照研究设计的代谢综合征与结直肠癌的相关性研究 [J]. 国际肿瘤学杂志, 2018, 45(9): 539-543.
|
| 15 |
霍瑞雪, 崔宇, 吴晓静, 等. 炎症介质及炎症细胞因子在结直肠癌发生发展中作用的研究进展 [J]. 山东医药, 2020, 60(3): 110-113.
|
| 16 |
Sankaranarayanan R, Kumar DR, Altinoz MA, et al. Mechanisms of Colorectal Cancer Prevention by Aspirin-A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways [J]. International Journal of Molecular Sciences, 2020, 21(23): 9018.
|
| 17 |
Lu Y, Eivin DNJ, Kristian H, et al. Metabolic predispositions and increased risk of colorectal adenocarcinoma by anatomical location: a large population-based cohort study in Norway [J]. American Journal of Epidemiology, 2015, 182(10): 883-893.
|
| 18 |
Esposito K, Chiodini P, Capuano A, et al. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis [J]. Endocrine, 2013, 44(3): 634-647.
|
| 19 |
Florescu A, Branisteanu D, Bilha S, et al. Leptin and adiponectin dynamics at patients with rectal neoplasm - Gender differences [J]. PLoS ONE, 2019, 14(8): e0212471.
|
| 20 |
Christen T, Trompet S, Noordam R,et al. Sex differences in body fat distribution are related to sex differences in serum leptin and adiponectin [J]. Peptides, 2018, 107: 25-31.
|
| 21 |
Dong Y, Zhou J, Zhu Y, et al. Abdominal obesity and colorectal cancer risk: systematic review and meta-analysis of prospective studies [J]. Bioscience Reports, 2017, 37(6): BSR20170945.
|
| 22 |
Brown JC, Caan BJ, Prado CM, et al. The association of abdominal adiposity with mortality in patients with stage I-III colorectal cancer [J]. Journal of the National Cancer Institute, 2020, 112(4): 377-383.
|
| 23 |
Aleksandrova K, Nimptsch K, Pischon T. Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk [J]. Current Nutrition Reports, 2013, 2(1): 1-9.
|
| 24 |
Riondino S, Roselli M, Palmirotta R, et al. Obesity and colorectal cancer: role of adipokines in tumor initiation and progression [J]. World Journal of Gastroenterology, 2014, 20(18): 5177-5190.
|
| 25 |
Swierczynski M, Szymaszkiewicz A, Fichna J, et al. New insights into molecular pathways in colorectal cancer: Adiponectin, interleukin-6 and opioid signaling [J]. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021, 1875(1): 188460.
|
| 26 |
Modzelewska P, Chludzińska S, Lewko J, et al. The influence of leptin on the process of carcinogenesis [J]. Contemporary Oncology, 2019, 23(2): 63-68.
|
| 27 |
Park HK, Kwak MK, Kim HJ, et al. Linking resistin, inflammation, and cardiometabolic diseases [J]. The Korean Journal of Internal Medicine, 2017, 32(2): 239-247.
|
| 28 |
Dalamaga M. Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives [J]. Biomarkers in Medicine, 2014, 8(1): 107-118.
|
| 29 |
Sever S, White DL, Garcia JM. Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review [J]. Endocrine-related Cancer, 2016, 23(9): R393-409.
|
| 30 |
Lin TC. The role of visfatin in cancer proliferation, angiogenesis, metastasis, drug resistance and clinical prognosis [J]. Cancer Management and Research, 2019, 11: 3481-3491.
|
| 31 |
Seretis A, Cividini S, Markozannes G,et al. Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies [J]. Scientific Reports, 2019, 9(1): 8565.
|
| 32 |
Xuan K, Zhao T, Chenyu S, et al. The association between hypertension and colorectal cancer: a meta-analysis of observational studies [J]. European Journal of Cancer Prevention, 2021, 30(1): 84-96.
|
| 33 |
Tangestani H, Salari-Moghaddam A, Ghalandari H, et al. Adherence to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern reduces the risk of colorectal cancer: A systematic review and meta-analysis [J]. Clinical Nutrition, 2020, 39(10): 2975-2981.
|
| 34 |
高庆, 张继民, 刘剑. 结直肠癌合并原发性高血压病理学相关性分析 [J]. 实用医学杂志, 2013, 29(008): 1268-1270.
|
| 35 |
Peeters P, Bazelier MT, Leufkens H, et al. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity [J]. Diabetes Care, 2015, 38(3): 495-502.
|
| 36 |
Ma Y, Yang W, Song M, et al. Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts [J]. British Journal of Cancer, 2018, 119(11): 1436-1442.
|
| 37 |
Valentina R, Alessandra T, Esther GL, et al. Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain [J]. Frontiers in Oncology, 2016, 6: 210.
|
| 38 |
He Q,Zhang H, Yao SW,et al. A study on relationship between metabolic syndrome and colorectal cancer [J]. Journal of B.U.ON., 2018, 23(5): 1362-1368.
|
| 39 |
Croft B, Reed M, Patrick C, et al. Diabetes, Obesity, and the Metabolic Syndrome as Prognostic Factors in Stages I to III Colorectal Cancer Patients [J]. Journal of Gastrointestinal Cancer, 2019, 50(2): 221-229.
|
| 40 |
Farahani H,Mahmoudi T, Asadi A, et al. Insulin Resistance and Colorectal Cancer Risk: the Role of Elevated Plasma Resistin Levels [J]. Journal of Gastrointestinal Cancer, 2020, 51(2): 478-483.
|
| 41 |
Tian Y, Wang KM, Li J, et al., The association between serum lipids and colorectal neoplasm: a systemic review and meta-analysis [J]. Public Health Nutrition, 2015, 18(18): 3355-3370.
|
| 42 |
Hong TT,Shen D, Chen XP, et al. Preoperative serum lipid profile and outcome in nonmetastatic colorectal cancer [J]. Chronic Diseases & Translational Medicine, 2016, 2(4): 241-249.
|
| 43 |
Fang Z,He MM, Song MY.Serum lipid profiles and risk of colorectal cancer: a prospective cohort study in the UK Biobank [J]. British Journal of Cancer, 2021, 124(3): 663-670.
|
| 44 |
Kim JS, Park EY, Park EJ, et al. Metabolic Syndrome and Colorectal Cancer Risk: Results of Propensity Score-Based Analyses in a Community-Based Cohort Study [J]. International Journal of Environmental Research and Public Health, 2020,17(22): 8687.
|
| 45 |
Pakiet A,Kobiela J, Stepnowski P, et al. Changes in lipids composition and metabolism in colorectal cancer: a review [J]. Lipids in Health and Disease, 2019,18(1): 29.
|